These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


405 related items for PubMed ID: 32228957

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments.
    Turk CT, Oz UC, Serim TM, Hascicek C.
    AAPS PharmSciTech; 2014 Feb; 15(1):161-76. PubMed ID: 24222270
    [Abstract] [Full Text] [Related]

  • 3. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F, Esnaashari SS, Bergonzi MC, Webster TJ, Younes HM, Khosravani M, Adabi M.
    Life Sci; 2020 Sep 01; 256():117943. PubMed ID: 32531377
    [Abstract] [Full Text] [Related]

  • 4. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y, Pan J, Feng SS.
    Int J Pharm; 2010 Aug 16; 395(1-2):243-50. PubMed ID: 20472049
    [Abstract] [Full Text] [Related]

  • 5. Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles.
    Esfandyari-Manesh M, Mostafavi SH, Majidi RF, Koopaei MN, Ravari NS, Amini M, Darvishi B, Ostad SN, Atyabi F, Dinarvand R.
    Daru; 2015 Apr 23; 23(1):28. PubMed ID: 25903677
    [Abstract] [Full Text] [Related]

  • 6. Paclitaxel-loaded star-shaped copolymer nanoparticles for enhanced malignant melanoma chemotherapy against multidrug resistance.
    Su Y, Hu J, Huang Z, Huang Y, Peng B, Xie N, Liu H.
    Drug Des Devel Ther; 2017 Apr 23; 11():659-668. PubMed ID: 28293102
    [Abstract] [Full Text] [Related]

  • 7. PLGA-LEC/F127 hybrid nanoparticles loaded with curcumin and their modulatory effect on monocytes.
    T Cruz J, Karen Álvarez, H Orozco V, Mauricio Rojas, A Morales-Luckie R, F Giraldo L.
    Nanomedicine (Lond); 2024 Jun 20; 19(15):1407-1423. PubMed ID: 38920352
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
    Tao W, Zeng X, Liu T, Wang Z, Xiong Q, Ouyang C, Huang L, Mei L.
    Acta Biomater; 2013 Nov 20; 9(11):8910-20. PubMed ID: 23816645
    [Abstract] [Full Text] [Related]

  • 10. Enhanced Entrapment and Improved in Vitro Controlled Release of N-Acetyl Cysteine in Hybrid PLGA/Lecithin Nanoparticles Prepared Using a Nanoprecipitation/Self-Assembly Method.
    Ahmaditabar P, Momtazi-Borojeni AA, Rezayan AH, Mahmoodi M, Sahebkar A, Mellat M.
    J Cell Biochem; 2017 Dec 20; 118(12):4203-4209. PubMed ID: 28419535
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
    Wu J, Zhang J, Deng C, Meng F, Zhong Z.
    Biomacromolecules; 2016 Jul 11; 17(7):2367-74. PubMed ID: 27305935
    [Abstract] [Full Text] [Related]

  • 13. Studying the effect of physically-adsorbed coating polymers on the cytotoxic activity of optimized bisdemethoxycurcumin loaded-PLGA nanoparticles.
    Mehanny M, Hathout RM, Geneidi AS, Mansour S.
    J Biomed Mater Res A; 2017 May 11; 105(5):1433-1445. PubMed ID: 28177570
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preparation and In Vitro/Vivo Evaluation of Folate-conjugated Pluronic F87-PLGA/TPGS Mixed Nanoparticles for Targeted Drug Delivery.
    Wu T, Gong Y, Li Z, Li Y, Xiong X.
    Curr Drug Deliv; 2021 May 11; 18(10):1505-1514. PubMed ID: 33845742
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development of Gemcitabine Loaded PLGA/Lecithin Nanoparticles for Non-Small Cell Lung Cancer Therapy.
    Esim O, Ozkan CK, Sarper M, Savaser A, Ozkan Y.
    Curr Drug Deliv; 2020 May 11; 17(7):622-628. PubMed ID: 32394837
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.